Wealth Enhancement Advisory Services
LUCD icon

Wealth Enhancement Advisory Services’s Lucid Diagnostics LUCD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
+26,393
New +$28.4K ﹤0.01% 4006

Other funds holding LUCD

SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Wealth Enhancement Advisory Services's LUCD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Lucid Diagnostics (LUCD) in Q2 2026: 26,393 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #4006 among its holdings.

8 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 26,393 shares of Lucid Diagnostics worth $26.4K as of Q2 2026.
  • Lucid Diagnostics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Lucid Diagnostics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4006 holding.
  • 8 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.